These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30993905)

  • 1. Metformin modifies disparity in hepatocellular carcinoma incidence in men with type 2 diabetes but without chronic liver diseases.
    Wang CP; Kuhn J; Shah DP; Schmidt S; Lam YF; MacCarthy D; Tenner L; Ramirez AG
    Cancer Med; 2019 Jun; 8(6):3206-3215. PubMed ID: 30993905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin for Reducing Racial/Ethnic Difference in Prostate Cancer Incidence for Men with Type II Diabetes.
    Wang CP; Lehman DM; Lam YF; Kuhn JG; Mahalingam D; Weitman S; Lorenzo C; Downs JR; Stuart EA; Hernandez J; Thompson IM; Ramirez AG
    Cancer Prev Res (Phila); 2016 Oct; 9(10):779-787. PubMed ID: 27026681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparity in liver cancer incidence and chronic liver disease mortality by nativity in Hispanics: The Multiethnic Cohort.
    Setiawan VW; Wei PC; Hernandez BY; Lu SC; Monroe KR; Le Marchand L; Yuan JM
    Cancer; 2016 May; 122(9):1444-52. PubMed ID: 26916271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
    Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
    Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma.
    Sahasrabuddhe VV; Gunja MZ; Graubard BI; Trabert B; Schwartz LM; Park Y; Hollenbeck AR; Freedman ND; McGlynn KA
    J Natl Cancer Inst; 2012 Dec; 104(23):1808-14. PubMed ID: 23197492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes.
    Tseng CH
    Liver Int; 2018 Nov; 38(11):2018-2027. PubMed ID: 29956875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Diabetes and Glucose-Lowering Therapies on Hepatocellular Carcinoma Incidence and Overall Survival.
    Hydes TJ; Cuthbertson DJ; Graef S; Berhane S; Teng M; Skowronska A; Singh P; Dhanaraj S; Tahrani A; Johnson PJ
    Clin Ther; 2022 Feb; 44(2):257-268. PubMed ID: 35078642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparities in hepatocellular carcinoma incidence among Hispanic and non-Hispanic adults in Arizona: Trends between 2009-2017.
    Morrill KE; Wightman P; Cruz A; Batai K; Block GD; Hsu CH; Garcia DO
    Ann Epidemiol; 2024 Aug; 96():48-52. PubMed ID: 38880361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial disparities in clinical presentation, surgical procedures, and hospital outcomes among patients with hepatocellular carcinoma in the United States.
    Chikovsky L; Kutuk T; Rubens M; Balda AN; Appel H; Chuong MD; Kaiser A; Hall MD; Contreras J; Mehta MP; Kotecha R
    Cancer Epidemiol; 2023 Feb; 82():102317. PubMed ID: 36566577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparities in hepatocellular carcinoma incidence by race/ethnicity and geographic area in California: Implications for prevention.
    Yang B; Liu JB; So SK; Han SS; Wang SS; Hertz A; Shariff-Marco S; Lin Gomez S; Rosenberg PS; Nguyen MH; Hsing AW
    Cancer; 2018 Sep; 124(17):3551-3559. PubMed ID: 30113700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparities in Hepatocellular Carcinoma Incidence in California: An Update.
    Sangaramoorthy M; Yang J; DeRouen MC; Ho C; Somsouk M; Tana MM; Thompson CA; Gibbons J; Gomez SL; Shariff-Marco S
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):79-87. PubMed ID: 31719066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
    Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
    Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination Therapy of Metformin and Statin May Decrease Hepatocellular Carcinoma Among Diabetic Patients in Asia.
    Chen HH; Lin MC; Muo CH; Yeh SY; Sung FC; Kao CH
    Medicine (Baltimore); 2015 Jun; 94(24):e1013. PubMed ID: 26091447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperglycemia and chronic liver diseases on risk of hepatocellular carcinoma in Chinese patients with type 2 diabetes--National cohort of Taiwan Diabetes Study.
    Li CI; Chen HJ; Lai HC; Liu CS; Lin WY; Li TC; Lin CC
    Int J Cancer; 2015 Jun; 136(11):2668-79. PubMed ID: 25387451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of meat and fat intake with liver disease and hepatocellular carcinoma in the NIH-AARP cohort.
    Freedman ND; Cross AJ; McGlynn KA; Abnet CC; Park Y; Hollenbeck AR; Schatzkin A; Everhart JE; Sinha R
    J Natl Cancer Inst; 2010 Sep; 102(17):1354-65. PubMed ID: 20729477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiazolidinediones, alpha-glucosidase inhibitors, meglitinides, sulfonylureas, and hepatocellular carcinoma risk: A meta-analysis.
    Arvind A; Memel ZN; Philpotts LL; Zheng H; Corey KE; Simon TG
    Metabolism; 2021 Jul; 120():154780. PubMed ID: 33891949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between etiology of hepatocellular carcinoma and race-ethnicity in Florida.
    Pinheiro PS; Medina HN; Callahan KE; Jones PD; Brown CP; Altekruse SF; McGlynn KA; Kobetz EN
    Liver Int; 2020 May; 40(5):1201-1210. PubMed ID: 32087002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of hepatocellular carcinoma in Hispanics in the United States.
    El-Serag HB; Lau M; Eschbach K; Davila J; Goodwin J
    Arch Intern Med; 2007 Oct; 167(18):1983-9. PubMed ID: 17923599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus and metformin in hepatocellular carcinoma.
    Fujita K; Iwama H; Miyoshi H; Tani J; Oura K; Tadokoro T; Sakamoto T; Nomura T; Morishita A; Yoneyama H; Masaki T
    World J Gastroenterol; 2016 Jul; 22(27):6100-13. PubMed ID: 27468203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin, Insulin Sensitivity, β-Cell Function, and Racial/Ethnic Disparity in Treatment Failure Rates in TODAY.
    Arslanian S; El Ghormli L; Bacha F; Caprio S; Goland R; Haymond MW; Levitsky L; Nadeau KJ; White NH; Willi SM;
    Diabetes Care; 2017 Jan; 40(1):85-93. PubMed ID: 27803118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.